Stay updated on SG vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the SG vs Docetaxel in NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page shows an updated revision label: v3.3.4 was added and the previous v3.3.3 was removed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new Locations section lists study sites across the US, Australia, and Puerto Rico (rev. 3.3.3). The page revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check46 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. This update shows the site versioning and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe PubMed publications note has been updated to clarify that publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study, and the revision indicator changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe site-wide notice about potential data delays due to a government funding lapse was removed from the page.SummaryDifference0.1%

- Check75 days agoChange DetectedOnly minor textual and layout adjustments are visible on the Study Details page; there are no changes to core content such as eligibility criteria, primary/secondary outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to SG vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.